Sionna Therapeutics IPO

Sionna Therapeutics is a life science company that aims to develop treatments for cystic fibrosis, which is a genetic disorder that affects the functioning of the lungs, pancreas, and other organs. Sionna Therapeutics was founded in 2019 and is headquartered in Boston, MA. The company researches drug treatments for the disorder striving to restore the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The CFTR protein is essential for the regulation of salt and water balance in the body.

Register for Details

For more details on financing and valuation for Sionna Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Sionna Therapeutics

Forge green plus iconForge green minus icon

What is Sionna Therapeutics's IPO price?

The IPO price for Sionna Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Sionna Therapeutics?

Sionna Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Sionna Therapeutics shares pre-IPO?

If you own Sionna Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Sionna Therapeutics a publicly traded company?

Sionna Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Sionna Therapeutics founded?

Sionna Therapeutics was founded in 2019.

Who are Sionna Therapeutics's major investors?

Viking Global Investors
Atlas Venture
Ra Capital Management
T. Rowe Price
Qatar Investment Authority
Perceptive Advisors
Cystic Fibrosis Foundation
Enavate Sciences
Updated on: Mar 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.